Aesthetic manufacturer Nordberg Medical invited practitioners to its Expert Forum in London on October 12, forming part of its international roadshow conference series.
Over the course of the roadshows, 500 aesthetic physicians will gather across eight cities to explore the science and clinical application of regenerative biostimulation, according to Nordberg Medical. Having kickstarted in Munich in September 2026 and concluding in Taipei in February 2027, the series explores the science and clinical application of collagen bio-regeneration, including Nordberg Medical’s PLLA-LASYNPRO platform, which is used in poly-L-lactic acid (PLLA) biostimulator JULÄINE.
The London forum, hosted by aesthetic physician Dr Jani van Loghem, featured aesthetic physician Dr Pawel Kubik and dermatologist Dr Susanne Kristof, alongside members of the Nordberg Medical UK Faculty, who shared clinical insights and evolving treatment approaches. The company shares that the programme followed four pillars; Diagnose, Discover, Apply and Integrate, guiding attendees through personalised assessment, scientific evidence, safe clinical practice and the delivery of meaningful, lasting patient outcomes.
Hannah Nolan, general manager UK & Ireland at Nordberg Medical, commented, “We were delighted to bring together our community of experienced JULÄINE users from across the UK & Ireland for a day of advanced clinical education, expert-led discussion and peer-to-peer exchange. Coming almost exactly a year after our official UK launch, it was the perfect moment to share the latest insights and science behind JULÄINE.”